Article
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Apr 2021
Lam Vincent K, Zhang Jianjun, Wu Carol C, Tran Hai T, Li Lerong, Diao Lixia, Wang Jing, Rinsurongkawong Waree, Raymond Victoria M, Lanman Richard B, Lewis Jeff, Roarty Emily B, Roth Jack, Swisher Stephen, Lee J Jack, Gibbons Don L, Papadimitrakopoulou Vassiliki A, Heymach John V
Abstract excerpt
INTRODUCTION: Plasma-based circulating tumor DNA (ctDNA) is an established biomarker for molecular profiling with emerging applications in disease monitoring in multiple tumor types, including, NSCLC. However, determinants of ctDNA shedding and correlation with tumor burden are incompletely understood, particularly in advanced-stage disease. METHODS: We retrospectively analyzed ctDNA-based and tissue-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
